Pragmatic clinical trials on minimally invasive diagnostics

This program broadly supports a range of entities and individuals dedicated to advancing cancer diagnostics, with a strong emphasis on collaborative, real-world clinical research. The goal is to improve patient lives, optimize healthcare outcomes, and provide evidence for integrating innovative diagnostic methods into national healthcare systems across Europe.

This program funds pragmatic clinical trials that focus on implementing and evaluating minimally invasive diagnostic interventions for cancer patients, aiming to improve healthcare outcomes and quality of life. The scope is centered on real-world effectiveness rather than early-stage translational research.

This funding program offers substantial grant opportunities for projects focused on cancer diagnostics, emphasizing a collaborative approach and a clear timeline for project completion.

Applicants must adhere to specific conditions for proposal submission, project implementation, and collaboration, with a particular focus on balanced project portfolios and societal impact.

The application process involves preparing detailed proposals and adhering to specific evaluation criteria, with clear guidelines provided through official EU documents.

This funding program operates under the comprehensive legal and regulatory framework established for Horizon Europe, ensuring transparency, accountability, and alignment with broader EU policies.